Cell Analysis Market Worth $23.0 Billion by 2018 - New Report By MarketsandMarkets

The major factors driving the growth of the cell analysis market are the rising incidence of cancer, corporate and government funding for cell-based research activities. http://www.marketsandmarkets.com/Market-Reports/cell-analysis-market-157543946.html

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
MarketsandMarkets

MarketsandMarkets

Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Sigma Aldrich (U.S.), Agilent Technologies (U.S.), Merck KGaA (Germany), Olympus Corporation (Japan), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.)

(PRWEB) June 27, 2014

The “Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, Qpcr), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis) - Global Forecast to 2018” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and the Rest of the World (RoW).

Browse 111 market data tables and 9 figures spread through 241 pages and in-depth TOC.
http://www.marketsandmarkets.com/Market-Reports/cell-analysis-market-157543946.html

Early buyers will receive 10% customization on this report.

Cell Analysis Market report studies the global cell analysis market over the forecast period of 2013 to 2018. The global cell analysis market was valued at an estimated $16.7 billion in 2013 and is expected to reach $23.0 billion by 2018, growing at a CAGR of 6.6% from 2013 to 2018.

For further inquiry click here at http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=157543946.

Enhanced accuracy of cell imaging and analysis systems helps in reducing the time and costs involved in the drug discovery process. This is a major factor driving the growth of the cell analysis market. Furthermore, the market is witnessing significant technological innovations and continuous improvements in cell analysis instruments and consumables for applications such as cell identification, cell proliferation, and target toxicity studies.

This is another factor propelling the growth of this market. Corporate and government support for the growth of innovative technologies and rising demand for outsourcing of drug discovery services, especially in the Asia-Pacific region, are also the major reasons for the high-growth of this market. Based on cell analysis products, the consumables market commanded the largest share of ~65.5% in 2013. However, the cell analysis instruments market is poised to grow at the highest CAGR from 2013 to 2018.

Request for customization of report at http://www.marketsandmarkets.com/requestCustomization.asp?id=157543946.

Based on geography, the global cell analysis market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America accounted for the largest share of the market in 2013. This large share of the North American region can be attributed to the presence of government funding and various collaborations among prominent players for developing and marketing new products in the market.

The major factors driving the growth of the cell analysis market are the rising incidence of cancer, corporate and government funding for cell-based research activities, rising incidence of chronic and infectious diseases, introduction of enhanced informatics solutions and improvements in image analysis products, and growing healthcare and medical spending. Moreover, the adoption of cell analysis for cell identification and cell signaling pathways/signal transduction pathways is the key growth opportunity in this market.

The major players in the cell analysis market include BD Biosciences (U.S.), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Sigma-Aldrich Corporation (U.S.), GE Healthcare (U.K.), Olympus (Japan), Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Merck KGaA (Germany), and Promega (U.S).

Browse Related Reports:
Cell-based Assays Market by Product [Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services], Application (Drug Discovery, ADMET), End-user (Pharmaceutical, CRO) - Global Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/cell-based-assays-market-119917269.html

Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global Forecasts to 2020
http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304,Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog at http://mnmblog.org/market-research/healthcare/biotechnology.
Connect with us on LinkedIn at http://www.linkedin.com/company/marketsandmarkets.


Contact

Follow us on: Contact's Google Plus